Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

NCT03614728 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
30
Enrollment
INDUSTRY
Sponsor class

Stopped Trial terminated due to internal review of clinical data in context of indication under investigation

Conditions

Interventions

Sponsor

GlaxoSmithKline